Valuation (33%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | 31.05 | 47.63 |
PEG Ratio (TTM) | 3.03 | 0.44 |
P/S Ratio (TTM) | 3.41 | 18.69 |
P/B Ratio (TTM) | 19.35 | 15.94 |
P/FCF Ratio (TTM) | 10.45 | 41.21 |
Price to 5YR AVG Earnings Ratio | N/A | 74.85 |
Price to 5YR AVG FCF Ratio | N/A | 101.28 |
Profitability (55%) |
Company | Industry |
---|---|---|
ROA (TTM) | 9.36% | -2.73% |
ROE (TTM) | 47.16% | 9.44% |
Net Profit Margin (TTM) | 10.93% | 4.63% |
ROIC 5YR AVG | N/A | 5.54% |
Growth (50%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 11.93% | -720.80% | N/A |
Revenue | 5.47% | 34.10% | N/A |
Net Income | 12.79% | -351.70% | N/A |
Cash Flow | 483.38% | 210.66% | N/A |
Health (32%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 1.07 | 1.88 |
Quick Ratio (TTM) | 1.07 | 1.87 |
D/E Ratio (TTM) | N/A | 0.51 |
Interest Coverage (TTM) | 13.88 | 12.85 |
Piotroski F-Score | 6 | 6 |
Altman Z-Score | 3.45 | 10.68 |
LTL to 5YR AVG FCF | N/A | 4.01 |
Shares Outstanding Growth 5YR AVG | N/A | 50.94% |